Thryve, a company specializing in B2B health data integration and analysis, has announced the successful completion of a Series A financing round of 4 million euros. Their API enables health services around the world to uniformly capture and analyze a person’s health status around the clock and across hundreds of health trackers, providing a crucial infrastructure component for preventive, automated care. The round was led by Belgian VC Capricorn Partners, with participation from IBB Ventures, as well as digital health-focused funds CRB from Spain and the German Carma Fund.You’ve Probably Already Used Thryve UnknowinglyThryve seamlessly integrates into other services, and it’s highly likely that each of us has already used Thryve without realizing it. In Europe alone, more than 50 million people have access to Thryve’s solution through bonus and prevention programs offered by health insurance providers like AOK in Germany and market leader Sanitas in Spain. Digital therapies, such as the DiGA top performer Sidekick Rx, which has both the highest total user numbers and the highest re-prescription rates for its obesity treatment Zanadio, also rely on Thryve to improve intervention and proactive care using tracker data.Demand and Potential Are EnormousThe shrinking working population combined with an aging population is leading to an increasing gap between health problems and healthcare capacity in industrialized countries worldwide. Adding to this challenge is the fact that in Germany alone, more than 30% of doctors will retire in the next five years. Digital health solutions enable more direct and simplified care, a market that is growing by over 20% annually, supported by policymakers, payers, and increasingly digital-savvy consumers. As now one in two people also uses a wearable or health tracker, the linkage of this data through Thryve is a crucial component for early disease detection and automated healthcare around the clock.It’s More Than Just Data AccessThryve aims to drive the fully automatic early detection and treatment of diseases at home by making the rapidly increasing data availability from health trackers not only easier to integrate but also by analyzing individual health data. The new financing will not only be used by Thryve to expand its customer base in more than 20 countries but also to significantly enhance its capabilities in analysis and health prevention. Currently, Thryve’s data platform enables assessments of mental health, heart health, or movement. Beyond expanding and exploring new health analyses in collaboration with more than 20 research partners, customers will also have the ability to run their own algorithms on the platform in the future.More Than Just Unifying InterfacesThryve’s data platform standardizes the integration of more than 100 data interfaces (APIs) and eliminates the complexity in accessing data from wearables such as the Apple Watch, Oura Ring, or specialized health sensors. Thryve processes more than one billion data records daily and provides cleansed, annotated data, certified for security (ISO27001) and quality (ISO9001). The company’s AI expertise became known during the COVID-19 pandemic when the data platform was used as part of the Robert Koch Institute’s COVID data donation for early infection detection.Antoine D´Hollander, Investment Director Capricorn Partners:“This investment aligns with our investment strategy, which aims to leverage real-world health data for personalized prevention and more effective therapies. We are excited about Thryve’s solution for creating a cost-effective health ecosystem through integrating data from numerous wearable devices and healthcare apps, enabling tailored, better healthcare.“Friedrich Lammel, CEO Thryve:“The healthcare industry is undergoing a fundamental transformation. I am convinced that with our platform, we are helping the industry to make millions of doctor visits unnecessary and extend people’s lives by 20 healthy years in the next five years. We are pleased to have the trust of leading European health investors in accelerating the digital transformation of the healthcare sector.“About ThryveThryve is a leading provider of health and fitness tracker integration. The company offers an API-based engine that enables unified access and comprehensive health analyses based on health trackers and wearables, saving IT costs in healthcare and enabling better care. With the mission to create a standard infrastructure for 24/7 access to health data and their interpretation, Thryve enables better, personalized prevention and comprehensive digital healthcare.For more information, visit www.thryve.healthAbout IBB VenturesIBB Ventures (www.ibbventures.de) has been providing venture capital for innovative companies in Berlin since 1997 and has established itself as a market leader in early-stage financing in Berlin. The funds are primarily used for the development and market introduction of innovative products or services, as well as for business concepts in the creative industry. In addition to the two VC funds for technology and creative companies with a volume of 90 million euros, an impact VC fund with a volume of 30 million euros has been in the investment phase since 2022. All three VC funds are financed by funds from the Investitionsbank Berlin (IBB) and the European Regional Development Fund (ERDF), managed by the State of Berlin. IBB Ventures has already invested in over 270 Berlin companies; in consortia with partners, the startups have received more than 1.8 billion euros, of which IBB Ventures has invested more than 290 million euros as a lead, co-lead, or co-investor. IBB Ventures is the umbrella brand for the VC activities of IBB Beteiligungsgesellschaft and is part of the IBB Group.Contact:Dr. Hannah-Sophie BraunIBB VenturesBundesallee 21010719 Berlin Tel: +49 (0)30 2125 3201Mail: info@ibbventures.de
